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Joubert syndrome (JS) is an autosomal recessive multisystem disease characterized by cerebellar vermis hypoplasia
with prominent superior cerebellar peduncles (the “molar tooth sign” [MTS] on axial magnetic resonance imaging),
mental retardation, hypotonia, irregular breathing pattern, and eye-movement abnormalities. Some individuals with
JS have retinal dystrophy and/or progressive renal failure characterized by nephronophthisis (NPHP). Thus far, no
mutations in the known NPHP genes, particularly the homozygous deletion of NPHP1 at 2q13, have been identiﬁed
in subjects with JS. A cohort of 25 subjects with JS and either renal and/or retinal complications and 2 subjects
with only juvenile NPHP were screened for mutations in the NPHP1 gene by standard methods. Two siblings
affected with a mild form of JS were found to have a homozygous deletion of the NPHP1 gene identical, by mapping,
to that in subjects with NPHP alone. A control subject with NPHP and with a homozygous NPHP1 deletion was
also identiﬁed, retrospectively, as having a mild MTS and borderline intelligence. The NPHP1 deletion represents
the ﬁrst molecular defect associated with JS in a subset of mildly affected subjects. Cerebellar malformations
consistent with the MTS may be relatively common in patients with juvenile NPHP without classic symptoms of JS.
Joubert syndrome (JS [MIM 213300]) is an autosomal
recessive disorder clinically characterized by congenital
hypotonia evolving into ataxia, developmental delay,
and either an abnormal breathing pattern (alternating
tachypnea and/or apnea), unusual eye movements, or
both (Joubert et al. 1969; Boltshauser and Isler 1977;
Saraiva and Baraitser 1992; Maria et al. 1999a; Parisi
and Glass 2003). The abnormal eye movements often
comprise oculomotor apraxia (OMA) or difﬁculty with
smooth eye pursuits and horizontal saccades, with jerk-
ing head thrusting and nystagmus (Vassella et al. 1972;
Tusa and Hove 1999). JS is characterized by the “molar
tooth sign” (MTS), a distinctive radiological ﬁnding that
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reﬂects a complex malformation of the midbrain and
hindbrain, consisting of increased interpeduncular dis-
tance at the pontomesencephalic junction; cerebellar ver-
mis hypoplasia; and thickened, straight, and elongated
superior cerebellar peduncles that resemble a molar
tooth on axial magnetic resonance imaging (MRI) (Ma-
ria et al. 1997, 1999b). No genes have been identiﬁed
as causative in JS, although genetic heterogeneity is
known to occur (Bennett et al. 2003), and two loci have
been mapped—to 9q34.3 (Saar et al. 1999) and to the
pericentromeric region of chromosome 11 (Keeler et al.
2003; Valente et al. 2003).
There is clinical heterogeneity in conditions such as
JS that are associated with the MTS, sometimes collec-
tively termed “cerebello-oculo-renal syndromes (CORS)”
or “Joubert syndrome-related disorders” (table 1). Some
children exhibit ocular colobomas, polydactyly, and liver
ﬁbrosis (Saraiva and Baraitser 1992; Chance et al. 1999).
A subset of children with JS has retinal dystrophy, some-
times described as Leber amaurosis or congenital retinal
blindness, and an association with renal disease has been
observed in this subgroup (JS type B) (King et al. 1984;
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Table 1
Features in CORS with the MTS
PRESENCE IN DISORDERa
CLINICAL FEATURES JSb,c
Dekaban-
Arima
Syndromed COACHd,e
Juvenile
NPHPf SLSg
Cogan
Syndromeh
MTS  () () ()i () ()
Hypotonia    () () ()
Mental retardation    () () ()
OMA  () () () () 
Breathing abnormalitiesj ()  () ? () 
NPHP ()  ()   ()
Cystic dysplastic kidneys ()     
Retinal dystrophyk ()  ?   
Coloboma ()     
Hepatic ﬁbrosis  ()  () () 
a  p present;  p absent; () p sometimes present; ? p unknown or not described.
b JS with retinal dystrophy and renal symptoms is sometimes designated type B.
c Genetic loci JBTS1, CORS2, NPHP1 (present results), and others.
d Genetic loci unknown or not described.
e COACH p cerebellar vermis hypoplasia, oligophrenia, ataxia, colobomas, and hepatic
ﬁbrosis.
f Genetic loci NPHP1, 2, 3, 4, and others.
g Genetic loci NPHP1, 3, 4, and others.
h Genetic loci NPHP1 and others unknown or not described.
i Present results.
j Episodic tachynpnea and/or apnea.
k May include severe congenital blindness deﬁned as Leber congenital amaurosis.
Saraiva and Baraitser 1992). A severe form of JS, with
congenital cystic dysplastic kidneys in conjunction with
retinal blindness, has been termed “Dekaban-Arima syn-
drome” (Dekaban 1969; Satran et al. 1999; Gleeson et
al. 2004). Juvenile-onset nephronophthisis (NPHP
[MIM 256100]) has been described in some individuals
with JS (Hildebrandt et al. 1998; Apostolou et al. 2001)
and is another renal manifestation occurring in this dis-
order. NPHP, or tubulointerstitial medullary cystic kid-
ney disease, presents with concentration defects and
leads to renal failure (i.e., end-stage renal disease
[ESRD]) within the ﬁrst 2 decades of life (Hildebrandt
et al. 1997b). Of individuals with NPHP, ∼15% also
have retinal dystrophy, a combination known as “Sen-
ior-Løken syndrome” (SLS [MIM 266900]) (Løken et
al. 1961; Senior et al. 1961; Caridi et al. 1998), and a
few individuals with SLS also demonstrate the MTS ac-
companied by mental retardation (Satran et al. 1999;
Gleeson et al. 2004). Four genes have been identiﬁed as
causative in individuals with NPHP or SLS (Hildebrandt
et al. 1997a; Otto et al. 2002, 2003; Olbrich et al. 2003),
and most have a familial form with autosomal recessive
inheritance (Otto et al. 2002), with ∼80% of patients
demonstrating an ∼290-kb homozygous deletion that
encompasses the NPHP1 gene at 2q13 (Konrad et al.
1996; Hildebrandt et al. 1997b, 2001; Saunier et al.
2000).
Given the ﬁnding of NPHP in a subset of patients with
JS, we sought to determine if the NPHP1 gene, impli-
cated as causative in the majority of familial cases of
NPHP, may also be involved in JS. Three groups
(W.B.D., J.G.G., and M.A.P.) evaluated their total cohort
of subjects with JS, as deﬁned by clinical criteria (Saraiva
and Baraitser 1992; Maria et al. 1999a; Parisi and Glass
2003), for those with either renal involvement, retinal
changes, or both. Fulﬁlling these criteria were 25 pro-
bands, with features summarized in table 2. Informed
consent for genetic studies from each patient or legal
guardian was obtained under protocols approved by the
authors’ respective institutional review boards. Of the
25 JS probands studied, 32% had both retinal and renal
involvement, whereas 24% had renal involvement alone,
and 44% had only retinal dysplasia. Five probands had
documented NPHP. For the three subjects without MRI
conﬁrmation of the MTS, cerebellar vermis hypoplasia
was reported on computed tomography scans, prior to
the description of the MTS (Maria et al. 1997). A pre-
sumptive diagnosis of SLS with the MTS was made in
three subjects.
Clinical details of the subjects with positive results for
NPHP1 analysis are summarized in table 3. Of special
interest, subject K76-1, who exhibited mild gross motor
delay, hypotonia, and mild cognitive delay, has a history
of a congenital head tilt and unusual eye movements.
She was diagnosed with NPHP at the age of 10 years
and is being treated with chronic peritoneal dialysis at
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Table 2
Summary of Clinical Characteristics of Subjects
Characteristic No. of Subjectsa %
Sex:
Female 14 56
Male 11 44
Consanguinity 4 16
MTS 22 88
OMA 12 48
Renal involvement: 14 56
Cystic kidney disease 7 28
NPHP 5 20
Other renal pathology 2 8
Retinal dystrophy: 19 76
LCAb 4 16
Colobomas 2 8
Combined retinal and renal involvement 8 32
a .Np 25
b LCA p Leber congenital amaurosis.
Table 3
Clinical Characteristics of Subjects with NPHP1 Mutations
Subject
Age
(years) Sex Alteration in NPHP1 NPHPa
Age at ESRD
(years)b
Retinal
Dystrophya OMAa MTSa
Developmental
Delaya
K76-1 11 F Homozygous deletion  10    (Mild) 
K76-2 8 F Homozygous deletion  NA   NE  (Mild motor)
K84-1 17 M Homozygous deletion  9    (Mild)  (Mild)
K89-1 15 M Deletion/W490fsX507  12    
a  p present;  p absent; NE p not examined.
b NA p not applicable.
age 11 years 8 mo. Her MRI scan at the age of 3 years
showed cerebellar vermis hypoplasia with long, mildly
thickened superior cerebellar peduncles, consistent with
a mild MTS (ﬁg. 1A and 1B and table 3). At 10 years
of age, she manifested cyclorotatory nystagmus with hy-
pometric saccades, consistent with a mild form of OMA.
The retinal examination was unremarkable, with normal
visual evoked potential and electroretinogram studies.
Her sister, subject K76-2, has a history of a head tilt and
mild gross motor delay but normal cognitive function.
She has difﬁculty with smooth pursuits on visual track-
ing, mild ataxia, and impaired balance. Her renal func-
tion, including renal ultrasound, blood urea nitrogen,
creatinine, and urine concentrating ability, were normal
at age 8 years. She has not had an MRI or recent
ophthalmologic examination. There is no history of
breathing abnormalities, tongue thrusting, colobomas,
or polydactyly in either sibling. Neither parent has cog-
nitive impairment, ataxia, retinal dystrophy, or renal dis-
ease, and there is no known consanguinity.
Two subjects with NPHP and known homozygous
and heterozygous NPHP1 deletions, respectively, were
recruited from the nephrology registry at the University
of Washington, to serve as controls for molecular anal-
yses. As summarized in table 3, subject K84-1 was di-
agnosed with NPHP at age 8 years and progressed to
ESRD and transplantation at age 9 years. He was iden-
tiﬁed elsewhere as having a homozygous deletion of
NPHP1 on genetic testing (R.M., unpublished data). He
had mild motor and learning delay, with an IQ of 76 at
the age of 6.5 years. He lacks OMA, retinal dystrophy,
and cerebellar signs, such as ataxia, but has mild inco-
ordination. However, an MRI revealed mild cerebellar
vermis hypoplasia with a mild MTS (ﬁg. 1C and 1D).
Subject K89-1 was diagnosed with NPHP at the age of
8 years and received a kidney transplant at age 14 years.
He had a heterozygous deletion of NPHP1, identiﬁed
by FISH analysis, with an unidentiﬁed second mutation
(R.M., unpublished data). He has normal development,
with neither ocular abnormalities nor retinal changes.
His MRI was normal, without the MTS (ﬁg. 1E and 1F).
Analysis of NPHP1 was performed on genomic DNA
isolated from peripheral blood or transformed cell lines
from affected individuals. The 20 exons and ﬂanking
30–50 nt at each intron-exon boundary of the NPHP1
gene were ampliﬁed by PCR with the use of standard
protocols, and the products were sequenced bidirection-
ally (primers and PCR conditions are available upon
request). No deleterious point mutations were identiﬁed
in any of the 25 probands included in the analysis. One
SNP described elsewhere was identiﬁed in exon 7 and
did not alter the encoded amino acid (Caridi et al. 2001).
Four additional intronic SNPs were identiﬁed in our co-
hort, as described in the SNP database (dbSNP). In one
proband and her sibling (K76-1 and K76-2), we were
unable to amplify any of the exons, suggesting a ho-
mozygous deletion of NPHP1. This ﬁnding was con-
ﬁrmed by Southern analysis, demonstrating the failure
of an internal NPHP1 probe to hybridize to DNA from
the sisters (ﬁg. 2) (Konrad et al. 1996). We also identiﬁed
the second mutation in control subject K89-1 withNPHP
alone and a heterozygous NPHP1 deletion (table 3).
Homozygous deletions in the NPHP1 gene were iden-
tiﬁed by evaluating the presence or loss of an STSmarker
(9657T) 3′ to the NPHP1 gene and within the common
deleted region (ﬁg. 3), with the use of an elsewhere de-
scribed procedure with minor modiﬁcations (Hilde-
brandt et al. 1998; Heninger et al. 2001). Subjects K76-
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Figure 1 Midline sagittal T1 images (A, C, and E) and associated axial T2 images through the level of the superior cerebellar peduncles
(SCPs) (B, D, and F) in subjects indicated above each column. Note the superiorly positioned fourth ventricle with moderate inferior vermis
hypoplasia (small white arrows) on the sagittal images of subjects K76-1 (A) and K84-1 (C), compared with the normal fourth ventricle with
mild inferior vermis deﬁciency in subject K89-1 (E). Elongated SCPs are demonstrated on axial images (B and D, black arrows), with associated
mild MTS, compared with normal SCPs (F).
1, K76-2, and K84-1 (known to have a homozygous
deletion of NPHP1) had this marker deleted. The hap-
lotype analysis of family K76 is consistent with inheri-
tance by each affected daughter of the same two alleles
from both parents, who each carry an NPHP1 deletion.
Several markers within the NPHP1 commonly deleted
region and within the 330-kb inverted repeat regions
(Saunier et al. 1997a, 2000; Nothwang et al. 1998) were
tested to map the extent of the homozygous NPHP1
deletion in subjects K76-1, K76-2, and K84-1 (ﬁg. 4).
We generated a junction fragment marker (junction-R),
at the boundary of the proximal 330-kb repeat and the
45-kb direct repeat, and new STS markers at the 5′ and
3′ regions of the genes within the commonly deleted re-
gion (LOC205251, NPHP1, and BENE), by inspection
of the UCSC human genome browser. Of note, a full
copy of the BENE gene was deleted, but the ﬁnal exon
that is known to be duplicated at the distal end of the
proximal 330-kb inverted repeat, outside the commonly
deleted interval (Saunier et al. 1997a), was present in
the deletion control subject K84-1. Characterization of
the deletion in these subjects with JS by STS mapping
showed concordance with the “classic” NPHP1 dele-
tion, seen in control subject K84-1 (ﬁg. 4). All STS mark-
ers located in the 330-kb inverted repeat region (47A,
53A, 57A, N123, R30E, R30A, and C40) were present
in subjects K76-1 and K76-2, suggesting that a homo-
zygous deletion encompassing a larger interval than that
seen in patients with classic NPHP can be excluded.
However, the presence of a larger-than-normal hetero-
zygous deletion in the affected members of family K76
cannot be excluded.
To exclude the presence of a compound heterozygous
mutation consisting of one deleted NPHP1 allele and a
cryptic point mutation in the other allele, we analyzed
a set of 10 polymorphic markers, including 5 microsat-
ellite markers described elsewhere (Heninger et al. 2001)
and the 5 intragenic SNPs within the common NPHP1
deletion region, in each of the 25 probands. The presence
of at least one heterozygous marker would indicate that
the patient does not harbor a full NPHP1 gene deletion.
For subjects in which parental and/or sibling DNA sam-
ples were available, haplotypes of the region encom-
passing the common 2q13 deletion were constructed, to
determine if the segregation pattern was suggestive of a
heterozygous deletion. For 21 of the subjects, excluding
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Figure 2 Southern analysis of EcoRI-digested genomic DNA
from members of family K76 and from control subjects, conﬁrming
the presence of a homozygous deletion of NPHP1 in the two affected
daughters (blackened circles). The probe is a 405-bp PCR fragment,
including exons 9–10 (forward primer: 5′-TGGAAAGCAAGTTCTT-
AGTAAGCAGCG-3′, reverse primer: 5′-GGCAGAATTTGGACTTG-
CTACCTTGA-3′). The number of wild-type alleles in control samples
is indicated by the genotype symbols underneath the black line (below
“NPHP1”). Dosage is apparent by intensity of the 3.94-kb band that
hybridizes to the intragenic NPHP1 probe. A ß-actin control probe
detected a band of almost equal intensity for all samples, conﬁrming
equal loading of DNA (data not shown).
K89-1, K84-1, and affected members of family K76, at
least one polymorphic marker or SNP within the com-
mon NPHP1 deletion region could be identiﬁed. In sev-
eral cases, familial haplotype segregation analysis pro-
vided further evidence against inheritance of a deleted
allele (data not shown). For three subjects, there was
insufﬁcient DNA available to complete the analysis. For
the three subjects with homozygous deletions, these
markers could not be ampliﬁed. As anticipated, analysis
of polymorphic markers within the deleted region did
not uncover any heterozygous alleles from control sub-
ject K89-1. These results provide evidence that none of
the subjects with JS is a heterozygous deletion carrier
in whom the second mutation was not identiﬁed by
mutational analysis.
The 18 families with JS that were suitable for hap-
lotype analysis (either multiplex families with at least
two affected children or those with consanguinity) were
analyzed for evidence of linkage, with the use of six
polymorphic microsatellite markers and one sequence-
tagged site (D2S2216, D2S293, D2S340, D2S1893, STS
9657T, D2S160, and D2S363) within a 27-Mb region
on chromosome 2q13 surrounding the NPHP1 gene.
Four of the probands in these families were part of the
set of 25 subjects included in the comprehensiveNPHP1
sequence analysis. Of the 18 families, all but one (K76)
were incompatible with linkage to 2q13 (data not
shown).
From these investigations, we have identiﬁed the ﬁrst
molecular defect associated with JS—a homozygous de-
letion of the NPHP1 gene—in two siblings with mild JS
and a documented MTS. However, on the basis of these
results, we believe that the frequency of this mutation
in the renal-retinal subtypes of JS, often termed “type
B,” is low, as it was only identiﬁed in 1 (4%) of 25
families in our cohort, which was selected for retinal
and/or renal involvement. Even in multiplex, unselected
families with JS, haplotype segregation analysis excludes
this locus in all but one family (K76), providing further
evidence that NPHP1 is not likely to be a major locus
associated with JS. In addition, other surveys, which
included a total of 12 families with 15 affected individ-
uals, have failed to identify the NPHP1 deletion in pa-
tients with JS type B (Hildebrandt et al. 1998; Apostolou
et al. 2001).
What, then, differentiates our subjects with JS and
NPHP1 deletions from other subjects with JS who do
not have the NPHP1 deletion? Our subjects with JS and
an NPHP1 deletion have a form of JS at the mild end
of the clinical spectrum for this disorder, as they are not
severely mentally retarded and their presenting symp-
toms in infancy were head tilt and mild hypotonia with
gross motor delay, with a lack of the respiratory dis-
turbance often seen in this disorder. In fact, the younger
sibling (K76-2) has not yet demonstrated cognitive delay.
Although the MTS was, in retrospect, visible on theMRI
of the older child (K76-1), this scan was interpreted ini-
tially as normal. Comprehensive ophthalmologic eval-
uation failed to identify any evidence of retinal dystro-
phy in the proband, indicating that these subjects are
not examples of JS type B, nor do they have SLS. It is
also intriguing that our NPHP deletion control subject,
K84-1, was identiﬁed as having a mild MTS, and we
established, retrospectively, the presence of nonspeciﬁc
delays prior to the onset of NPHP. Although this subject
has the MTS, he does not fulﬁll all clinical criteria for
JS (Saraiva and Baraitser 1992;Maria et al. 1999a; Parisi
and Glass 2003). Thus, the severity of the pleiotropic
features in JS appears to be variable.
Extrarenal ﬁndings have been described in some in-
dividuals with NPHP (Antignac et al. 1998). There are
several reports of families with congenital OMA (Cogan
syndrome) accompanied by NPHP who have docu-
mented deletions and/or point mutations in the NPHP1
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Figure 3 Haplotype analysis in family K76, showing markers
compatible with linkage to the 2q13 region surrounding NPHP1. The
deleted STS marker 9657T is indicated in affected subjects K76-1 and
K76-2. The 290-kb deletion is mediated by two inverted duplicated
segments (invdup) of ∼330 kb each, via a complex mechanism.
gene (Saunier et al. 1997b; Betz et al. 2000). Some in-
dividuals with Cogan syndrome have abnormalities of
the cerebellar vermis (Whitsel et al. 1995; Sargent et al.
1997). One recent case report showed hypoplasia of the
brainstem and cerebellar vermis in a boy with NPHP
and homozygous deletion of NPHP1 (Takano et al.
2003); in fact, this child may have a JS phenotype that
was not recognized, but conﬁrmation from the provided
MRIs is impossible. We suspect that several of these
patients with NPHP or Cogan syndrome with cerebellar
involvement and NPHP1 mutations may have an MTS
not identiﬁed explicitly (Saunier et al. 1997b; Betz et al.
2000; Takano et al. 2003); however, since MRI details
are not included in these reports, this assertion remains
speculative. In two separate series of MRI ﬁndings in
patients with Cogan syndrome ( ), at least threenp 21
of the images show the MTS, but these cases were pub-
lished before the MTS was recognized and the associ-
ation with NPHP1 mutations was established (Whitsel
et al. 1995; Sargent et al. 1997). Systematic evaluations
by cranial MRI studies of the cerebellum in individuals
with NPHP to identify the MTS have not been described.
Presumably, other children with NPHP and either SLS
or learning delays have been screened for NPHP1 de-
letions, and some may have had this molecular abnor-
mality without being considered as affected with JS. This
lack of diagnostic assignment to JS may be owing to
either lack of MRI studies or failure to identify the MTS
even if an MRI scan was obtained. In our NPHP het-
erozygous control subject (K89-1), with a known intra-
genic frameshift mutation of NPHP1 in association with
the classic deletion, an essentially normal cerebellum is
present on MRI without the MTS. Thus, there is likely
to be a spectrum of cerebellar ﬁndings on MRI in sub-
jects with NPHP1-associated NPHP, with the majority
not exhibiting a typical MTS. Until comprehensive sur-
veys of brain imaging studies of patients with NPHP are
undertaken, the question of what proportion of subjects
with only NPHP manifests an MTS will remain
unresolved.
One of the questions that arises from these results is
whether the NPHP1 deletion in JS patients is different
from that described in patients with NPHP alone. On
the basis of the available evidence, given the current
limitations of mapping breakpoints within a complex
repetitive region of the human genome, the deletion ap-
pears to be identical to the classic deletion in patients
with NPHP. Although three genes reside within the
unique deleted NPHP1 locus (LOC205251, NPHP1,
and BENE), only NPHP1 has been implicated in the
etiology of NPHP, and no differences in the extent of
the deletion between subjects were identiﬁed by STS
mapping. A more subtle or complex rearrangement, such
as a second larger heterozygous deletion, cannot be ex-
cluded by the current analysis. Such a heterozygous de-
letion in combination with the common deletion may
expand the disease phenotype because of the deletion of
one (or more) dosage-sensitive gene(s). However, sup-
port for a common shared deletion that results in a broad
clinical phenotype is provided by identiﬁcation of the
identical deletion in subjects who have NPHP with and
without OMA (in both cases, some subjects are hetero-
zygous for a deletion and a point mutation) (Saunier et
al. 1997b; Betz et al. 2000) and by large genomic de-
letions mediated by duplicated repetitive elements that
cause disorders, such as Charcot-Marie-Tooth syndrome
and neuroﬁbromatosis type 1, with highly variable phe-
notypes despite a common mechanism (Stankiewicz and
Lupski 2002).
If the NPHP1 deletion is the same in NPHP, JS, and
other CORS, what accounts for the widely divergent
phenotypes? One possibility is that the other ORFs
within the NPHP1 deleted region may contribute to the
CORS phenotypes through unknown genetic or epige-
netic factors, as their functions have not yet been com-
pletely elucidated. One of these genes, BENE, appears
to encode a protein involved in membrane trafﬁcking
in apical cells of various tissues, including the renal
epithelium (de Marco et al. 2001).
Alternatively, other as-yet unknown genes outside of
the 2q13 deletion may work in concert with NPHP1 to
contribute to OMA or to the MTS brain malformation
and other clinical features that typify JS and related dis-
orders. The nephrocystin protein encoded by NPHP1 is
hypothesized to be important in mediating cell adhesion
and signal transduction in the ciliated kidney epithelium
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Figure 4 Comparison of the NPHP1 deletion in subjects with JS (K76-1 and K76-2) and in a control subject with the classic deletion
(K84-1). The results of STS deletion mapping are indicated in C and D as ticks (to indicate the marker was present in these three subjects) and
crosses (to indicate the marker was absent in all three subjects). A, Scale bar indicating 850 kb of contiguous DNA sequence at 2q13, isolated
from the UCSC genome browser. B, BAC clone contig of the interval. (Note that clone 385J6 ﬂanks both ends, demonstrating the difﬁculty
presented by genomic duplications in generating accurate contigs.) C, Map of STS markers in the region that was used for deletion mapping.
The NPHP1 deletion interval is indicated by a gray bar, and arrow diagrams outline the repeat regions: large blue arrows indicate the 330-kb
inverted repeat, and short black arrows indicate the three copies of the 45-kb repeat, of which the two direct repeats are known to mediate
unequal crossover. D, Gene locations included within the region encompassing the 45-kb repeats, mapped with orientation indicated by
arrowheads. The shaded gray box indicates the only unique DNA sequence of the deleted region, which includes LOC205251, NPHP1, and
all but the 3′ portion of the BENE gene.
(Konrad et al. 1996; Hildebrandt et al. 1997a; Otto et
al. 2003) and interacts with the NPHP2, NPHP3, and
NPHP4 proteins in a multimeric complex (Mollet et al.
2002; Olbrich et al. 2003; Otto et al. 2003). These other
NPHP genes may contribute to the CORS phenotype
via rare polymorphisms, thereby acting as potential ge-
netic modiﬁers. Alternatively, JS, like Bardet-Biedl syn-
drome, may be due to a complex genetic segregation
pattern, known as triallelic inheritance, in which some
affected individuals must inherit three, rather than two,
separate disease-associated alleles in order to manifest
the complete disorder (Katsanis et al. 2001; Beales et al.
2003). Under this hypothesis, another JS locus, in ad-
dition to NPHP1, may harbor a mutation that modu-
lates the phenotype of the NPHP1 deletion, generating
the JS phenotype. Indirect evidence for this hypothesis
is provided by nonconsanguineous pedigrees linked to
the NPHP3 locus, in that only one NPHP3 mutation
was identiﬁed in six of seven families with NPHP
(Olbrich et al. 2003), suggesting that other genes (in-
cluding other NPHP genes) may be providing a second
or third mutation necessary to cause disease. In addition,
the development of renal disease in mice deﬁcient for
the murine ortholog of NPHP3 (pcy) has been shown
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to be highly dependent on modiﬁer loci, with 37% of
the variance in renal cyst phenotype owing to a single
locus in the region of the mouse NPHP2 gene (Woo et
al. 1997; Otto et al. 2003). Thus, it is highly likely that
modiﬁer loci inﬂuence the known phenotypic variability
in human renal cystic disorders. Since there is known
genetic heterogeneity in JS, complex inheritance remains
a formal possibility but is not testable until additional
causative genes for JS are identiﬁed. An obvious next
step is to examine the other recently identiﬁed NPHP
genes for mutations in patients with JS.
The evidence for a role of NPHP1 in brain develop-
ment remains unexplored. Although known to be ex-
pressed in a wide variety of tissues that includes skeletal
muscle, heart, pancreas, and brain in addition to kidney,
the temporospatial and developmental expression in the
cerebellum has not been documented. It is possible that
NPHP1, in addition to its hypothesized roles in cell ad-
hesion and primary ciliary function in the epithelia of
the kidney and retina (Caridi et al. 1998; Otto et al.
2002, 2003; Olbrich et al. 2003), may also have a similar
function in cells important in embryonic brain devel-
opment. Other examples of proteins with related func-
tions are those whose genes cause conditions, such as
Bardet-Biedl syndrome and other hepatorenal ﬁbrocystic
syndromes, for which common genetic mechanisms are
being clariﬁed (reviewed in Johnson et al. [2003] and in
Watnick and Germino [2003]).
Finally, any child with the MTS and either JS, Cogan
syndrome, SLS, or NPHP should be considered for de-
letion analysis of the NPHP1 gene. Subjects with OMA
or JS are at risk for the development of NPHP, and
routine screening for renal compromise is recommended
in this cohort (Parisi and Glass 2003). It is hoped that
as additional causative genes for JS and related CORS
are identiﬁed, the association of speciﬁc phenotypeswith
known genotypes will be elucidated.
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